Fetal effects of cocaine: an updated meta-analysis
Introduction
The high prevalence of cocaine use has become a major health concern during pregnancy. Cocaine crosses the human placenta, with varying proportions absorbed by the placenta, suggesting that the placenta may offer a degree of protection to some fetuses after bolus administration [1]. Cocaine is a CNS stimulant with effects thought to be due to its sympathomimetic-driven fetal, uterine, or maternal vasoconstriction and hypertension leading to infarcts or hemorrhages at any time during gestation and in any structure. This feature may explain the variability of clinical effects attributed to cocaine use. A typical well-defined “fetal cocaine syndrome” has not been identified [2]; however, exposure to cocaine during pregnancy has been associated with shorter gestation, premature delivery, abruptio placenta, and other maternal and neonatal adverse effects. In the past, congenital malformations of almost every system have been reported leading many clinicians to believe that the drug is teratogenic [3]. Reports of fetal cocaine effects have been controversial and it has been difficult to elucidate these effects, because interpretation of the results is hampered by the fact that cocaine use is commonly accompanied by confounding factors such as concomitant use of cigarettes and other recreational drugs, including heroin, cannabis, methadone, and others, all of which may affect pregnancy outcome by themselves.
Our original systematic review and meta-analysis in 1991 [4] suggested that cocaine exposure during pregnancy is not a major risk for malformation (except for the genitourinary tract). When cocaine users were compared to women not consuming any drugs of abuse, a variety of risks emerged. Yet when we compared pregnancy and neonatal outcomes in children of cocaine consumers with polydrug consumers, the increased risk for most of the adverse outcomes was nullified. A major issue at that stage was the relatively small number of studies for each adverse end point. Since 1989 (the last year included in our previous meta-analysis), however, scores of studies on cocaine exposure during pregnancy have been published. Hence, the present meta-analysis has allowed us to separate the exposure data into several comparisons:
- 1.
between all combinations of exposures that involve cocaine use during pregnancy (cocaine alone, polydrug including cocaine, polydrug not including cocaine);
- 2.
between the different methodologies used to determine exposure (urine analysis, maternal interview, chart review).
The aim of this updated meta-analysis was to arrive at an overall quantitative estimate of the effect of cocaine use on pregnancy outcome and potential pregnancy complications, with a substantially increased power.
Section snippets
Data sources
The medical literature published between January 1989 and December 1997 was searched for papers dealing with the outcome of pregnancy following gestational cocaine exposure. The literature search was performed in the MEDLINE and EMBASE bibliographic databases. A search strategy using a combination of “pregnancy ” or “abnormalities drug induced ” and “cocaine ” keywords (MeSH) was used. All references in the retrieved articles were screened for further papers. From all the references we excluded
Results
More than 600 scientific references were considered because they deal with the human effects of cocaine used during pregnancy, with an exponential growth in number of papers published in recent years. Of these, 516 studies were retrieved and, based on a review of their methods sections, only 36 studies met the inclusion criteria for this analysis. Of these 36 studies, 3 studies [6], [7], [8] were excluded after a more detailed analysis because in these studies there were multiple exposures in
Discussion
Because very large numbers of women in the reproductive age group consume cocaine, there are serious concerns regarding the long term health of millions of children exposed in utero to this recreational drug [2]. An issue widely recognized by researchers and clinicians is that, in addition to cocaine, many other risk factors occur and may adversely affect infants exposed in utero to cocaine. These include other drugs of abuse and cigarettes, alcohol, poor prenatal care, single motherhood, and
References (43)
- et al.
Meta-analysis in clinical trials
Controlled Clinical Trials
(1986) - et al.
Maternal and neonatal characteristics following exposure to cocaine in Toronto
Reproductive Toxicology
(1993) - et al.
Cocaine abuse during pregnancyperipartum prevalence and perinatal outcome
American Journal of Obstetrics & Gynecology
(1989) - et al.
Maternal and neonatal effects of moderate cocaine use during pregnancy
Neurotoxicol Teratol
(1991) - et al.
Teratogenicity of cocaine in humans
J Pediatr
(1987) - et al.
Peripartum cocaine useestimating risk of adverse pregnancy outcome
Int J Gynaecol Obstet
(1991) - et al.
Cocaine use in pregnancy;perinatal morbidity and mortality
Neurotoxicol Teratol
(1987) - et al.
Prenatal cocaine usea comparison of neonates matched on maternal risk factors
Neurotoxicol Teratol
(1994) - et al.
The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening
American Journal of Obstetrics & Gynecology
(1990) - et al.
Ocular signs of cocaine intoxication in neonates
American Journal of Ophthamology
(1987)
The biologic and social consequences of perinatal cocaine use in an inner-city populationresults of an anonymous cross-sectional study
American Journal of Obstetrics & Gynecology
Cocaine use during pregnancyadverse perinatal outcome
American Journal of Obstetrics & Gynecology
Prevalence of use of cocaine and other substances in an obstetric population
American Journal of Obstetrics & Gynecology
Meconium testing for cocaine metaboliteprevalence, perceptions, and pitfalls
American Journal of Obstetrics & Gynecology
Cocaine abuse in pregnancy
Neurotoxicol Teratol
Adverse perinatal outcome in parturients who use crack cocaine
Obstet Gynecol
Prenatal cocaine exposure and the development of the human eye
Ophthalmology
Effect of cocaine use on the fetus
New Engl J Med
Relationship between gestational cocaine use and pregnancy outcomea meta-analysis
Teratology
Cited by (134)
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey
2023, TherapiesCitation Excerpt :During pregnancy, such issues affect uteroplacental blood flow [47]. Prenatal cocaine exposure is significantly associated with preterm birth, placental abruption, premature rupture of membranes, low birth weight, and small for gestational age infants [48,49]. Congenital malformations related to cocaine are discussed, even if cleft palate and genitourinary tract malformations have been reported [50–52].
Pregnancy outcome among women with drug dependence: A population-based cohort study of 14 million births
2020, Journal of Gynecology Obstetrics and Human ReproductionCitation Excerpt :We found that women with DDP had an increased risk of antepartum hemorrhage. The association of cocaine use and increased risk of placental abruption has been well established [14,33,34]. Recently, opioid use in pregnancy was reported to correlate with greater risk of third trimester bleeding [35].
Acute psychiatric illness and drug addiction during pregnancy and the puerperium
2020, Handbook of Clinical NeurologyHospital Variation in Child Protection Reports of Substance Exposed Infants
2019, Journal of PediatricsTeratology
2019, Fetal Medicine: Basic Science and Clinical PracticeHydrops and fetal hypoplastic left heart: An unexpected improvement after cessation of maternal polysubstance abuse
2018, Journal of Gynecology Obstetrics and Human Reproduction